Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 54 of 1714:
44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Gene Compound Assay Inh Ic50 Ki View
tachykinin receptor 2 TERFENADINE Tachykinin NK2 80% 2.677uM .892uM View
Sigma-2 Receptor THIORIDAZINE Sigma2 80% .845uM .52uM View
Protein-tyrosine kinase, Fyn MONTELUKAST Protein Tyrosine Kinase, Fyn 80% 4.702uM NoneNone View
Protein-tyrosine kinase, Fyn THIORIDAZINE Protein Tyrosine Kinase, Fyn 80% 5.05uM NoneNone View
cholinergic receptor, muscarinic 5 METHAPYRILENE Muscarinic M5 80% 3.265uM 2.346uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 DIMENHYDRINATE Dopamine Transporter 80% 2.245uM 1.784uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 METHAPYRILENE Dopamine Transporter 80% 2.757uM 2.19uM View
dopamine receptor D1A FLUNARIZINE Dopamine D1 80% 3.874uM 1.937uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 CISAPRIDE CYP450-3A4 Inhibition 80% .3uM NoneNone View
Cytochrom P450-2D6 monooxygenase METOCLOPRAMIDE CYP450-2D6 Inhibition 80% .8uM NoneNone View
Cytochrom P450-2D6 monooxygenase NALTREXONE CYP450-2D6 Inhibition 80% 1uM NoneNone View
Cytochrom P450-2D6 monooxygenase CLEMASTINE CYP450-2D6 Inhibition 80% 3uM NoneNone View
Cytochrom P450-2C19 monooxygenase CHLORMADINONE ACETATE CYP450-2C19 Inhibition 80% 3uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DOBUTAMINE Serotonin Transporter 80% 1.895uM 1.006uM View
lymphocyte protein tyrosine kinase (mapped) GRAMICIDIN Protein Tyrosine Kinase, Lck 80% 1.094uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ETHYLESTRENOL Adrenergic, Norepinephrine Transporter 80% 2.098uM 2.08uM View
opioid receptor, sigma 1 QUETIAPINE Sigma1 80% 2.2935uM .9639uM View
calcium channel, voltage-dependent, gamma subunit 1 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, beta 4 subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, beta 3 subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, beta 2 subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, alpha 1F subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) TENOXICAM Cyclooxygenase COX-1 83% 1.14uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) CYCLIZINE Adrenergic alpha1D 83% 1.215uM .597uM View
Cytochrom P450-2D6 monooxygenase PAROXETINE CYP450-2D6 Inhibition 83% 1uM NoneNone View
adrenergic receptor, alpha 2a PENTAMIDINE Adrenergic alpha2A 83% 1.375uM .516uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 PENTAMIDINE Adrenergic, Norepinephrine Transporter 83% 2.214uM 2.196uM View
cholinergic receptor, muscarinic 3 PROCHLORPERAZINE Muscarinic M3 83% 1.514uM .321uM View
potassium voltage-gated channel, subfamily H, member 8 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 DOXAZOSIN Potassium Channel HERG 83% 2.2155uM 1.8151uM View
potassium voltage-gated channel, subfamily H, member 8 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 PERPHENAZINE Potassium Channel HERG 83% 4.216uM 3.4541uM View
leukotriene B4 receptor 2 SULOCTIDIL Leukotriene B4 83% 1.4405uM .3655uM View
leukotriene B4 receptor SULOCTIDIL Leukotriene B4 83% 1.4405uM .3655uM View
leukotriene B4 receptor SULOCTIDIL Leukotriene B4 83% 1.4405uM .3655uM View
leukotriene B4 receptor 2 SULOCTIDIL Leukotriene B4 83% 1.4405uM .3655uM View
aldo-keto reductase family 1, member B4 (aldose reductase) PIRINIXIC ACID Aldose Reductase 83% 2.8169uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) PIRINIXIC ACID Aldose Reductase 83% 2.8169uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) PIRINIXIC ACID Aldose Reductase 83% 2.8169uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) PIRINIXIC ACID Aldose Reductase 83% 2.8169uM NoneNone View
opioid receptor, sigma 1 THIORIDAZINE Sigma1 83% .363uM .153uM View
opioid receptor, sigma 1 1,3-DIPHENYLGUANIDINE Sigma1 83% 1.696uM .713uM View
mitogen activated protein kinase 3 IODOQUINOL Protein Serine/Threonine Kinase, ERK1 83% 5.264uM NoneNone View
mitogen-activated protein kinase 3 IODOQUINOL Protein Serine/Threonine Kinase, ERK1 83% 5.264uM NoneNone View
opioid receptor, kappa 1 THIORIDAZINE Opiate kappa 83% 2.49uM .996uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PROPAFENONE Dopamine Transporter 83% 1.868uM 1.484uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, beta 1 subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 8 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 7 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 6 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 5 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, nonvoltage-gated 1 alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type X, alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type IX, alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage gated, type VIII, alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type VII, alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type IV, beta TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type IV, alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type III, alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type II, beta TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type II, alpha 2 TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type I, beta TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
sodium channel, voltage-gated, type I, alpha TETRACAINE Sodium Channel, Site 2 81% 1.7uM 1.551uM View
cholinergic receptor, muscarinic 2 GALLAMINE TRIETHIODIDE Muscarinic M2 81% 1.999uM .711uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 THIMEROSAL Adrenergic, Norepinephrine Transporter 81% .931uM .923uM View
dopamine receptor D1A BENZOTHIAZYL DISULFIDE Dopamine D1 81% 1.189uM .595uM View
aldo-keto reductase family 1, member B4 (aldose reductase) CAFFEIC ACID PHENETHYL ESTER Aldose Reductase 81% 1.414uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) CAFFEIC ACID PHENETHYL ESTER Aldose Reductase 81% 1.414uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) CAFFEIC ACID PHENETHYL ESTER Aldose Reductase 81% 1.414uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) CAFFEIC ACID PHENETHYL ESTER Aldose Reductase 81% 1.414uM NoneNone View
prostaglandin-endoperoxide synthase 1 CAPSAICIN Cyclooxygenase COX-1 81% 1.551uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) CAPSAICIN Cyclooxygenase COX-1 81% 1.551uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 LABETALOL Adrenergic, Norepinephrine Transporter 81% 3.354uM 3.326uM View
adrenergic receptor, alpha 2c (Non-specific probe) TRAZODONE Adrenergic alpha2C 81% 1.942uM .282uM View
adrenergic receptor, alpha 2b TRAZODONE Adrenergic alpha2C 81% 1.942uM .282uM View
Sigma-2 Receptor TRAZODONE Sigma2 81% 1.342uM .826uM View
aldo-keto reductase family 1, member B4 (aldose reductase) TICRYNAFEN Aldose Reductase 81% 3.206uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) TICRYNAFEN Aldose Reductase 81% 3.206uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) TICRYNAFEN Aldose Reductase 81% 3.206uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) TICRYNAFEN Aldose Reductase 81% 3.206uM NoneNone View
adrenergic receptor, alpha 2a MOSAPRIDE Adrenergic alpha2A 81% 3.6794uM 1.3798uM View
adrenergic receptor, alpha 1a CITALOPRAM Adrenergic alpha1A 81% 1.756uM .711uM View
adrenergic receptor, alpha 2b LYSERGOL Adrenergic alpha2C 81% 1.61uM .234uM View
adrenergic receptor, alpha 2c (Non-specific probe) LYSERGOL Adrenergic alpha2C 81% 1.61uM .234uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) 1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE CYP450-2C9 Inhibition 81% 2uM NoneNone View
sodium channel, voltage-gated, type II, beta CYCLIZINE Sodium Channel, Site 2 81% 3.091uM 2.82uM View
sodium channel, voltage-gated, type II, alpha 2 CYCLIZINE Sodium Channel, Site 2 81% 3.091uM 2.82uM View
sodium channel, voltage-gated, type I, beta CYCLIZINE Sodium Channel, Site 2 81% 3.091uM 2.82uM View
sodium channel, voltage-gated, type I, alpha CYCLIZINE Sodium Channel, Site 2 81% 3.091uM 2.82uM View
cholinergic receptor, muscarinic 2 HYDROXYCHLOROQUINE Muscarinic M2 81% 2.951uM 1.049uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) PHENELZINE CYP450-2C9 Inhibition 81% 4uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 PHENELZINE CYP450-2C9 Inhibition 81% 4uM NoneNone View
Cytochrom P450-2C19 monooxygenase NORETHINDRONE ACETATE CYP450-2C19 Inhibition 81% .8uM NoneNone View
adrenergic receptor, alpha 2a BERBERINE CHLORIDE Imidazoline I2, Central 81% 1.278uM .852uM View
adrenergic receptor, alpha 2c (Non-specific probe) BERBERINE CHLORIDE Imidazoline I2, Central 81% 1.278uM .852uM View
mu-opioid receptor MOR BITHIONOL Opiate mu 81% 5.507uM 2.236uM View
5-hydroxytryptamine (serotonin) receptor 1A BITHIONOL Serotonin 5-HT1A 81% 5.515uM 3.152uM View
thromboxane A synthase 1 VINBLASTINE Thromboxane Synthetase 81% 1.87uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) VINBLASTINE Thromboxane Synthetase 81% 1.87uM NoneNone View
Sigma-2 Receptor DOBUTAMINE Sigma2 81% 2.6uM 1.6uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 BENZTROPINE Adrenergic, Norepinephrine Transporter 81% 1.391uM 1.379uM View
5-hydroxytryptamine (serotonin) receptor 2A BUSPIRONE Serotonin 5-HT2A 81% 2.286uM .653uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, beta 1 subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, gamma subunit 8 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, gamma subunit 7 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, gamma subunit 6 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, gamma subunit 5 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, gamma subunit 4 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, gamma subunit 3 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
calcium channel, voltage-dependent, gamma subunit 2 NITRENDIPINE Calcium Channel Type L, Benzothiazepine 80% .001565uM .001391uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 NELFINAVIR Adrenergic, Norepinephrine Transporter 80% 8.852uM 8.779uM View
nuclear receptor subfamily 3, group C, member 1 17-METHYLTESTOSTERONE Glucocorticoid 80% 1.843uM .838uM View
adrenergic receptor, alpha 1b TERFENADINE Adrenergic alpha1B 80% 3.335uM 1.846uM View
progesterone receptor FLUOROMETHOLONE Progesterone 80% .815uM .106uM View
progesterone receptor FLUOROMETHOLONE Progesterone 80% .815uM .106uM View
adrenergic receptor, alpha 2a PERGOLIDE Imidazoline I2, Central 80% 3.075uM 2.05uM View
adrenergic receptor, alpha 2c (Non-specific probe) PERGOLIDE Imidazoline I2, Central 80% 3.075uM 2.05uM View
thromboxane A synthase 1 GW-1929 Thromboxane Synthetase 80% 2.953uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) GW-1929 Thromboxane Synthetase 80% 2.953uM NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel, voltage-gated, type IV, beta PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
sodium channel, voltage-gated, type IV, alpha PIPAMAZINE Sodium Channel, Site 2 80% 2.686uM 2.451uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H, member 8 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 RISPERIDONE Potassium Channel HERG 80% 4.1901uM 3.4328uM View
sodium channel, voltage-gated, type IV, beta BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type IV, alpha BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type III, alpha BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type II, beta BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type II, alpha 2 BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type I, beta BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type I, alpha BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type IV, beta BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel associated protein 1 BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel associated protein 2 BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type III, beta BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type I, alpha BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type IX, alpha BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type VII, alpha BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
amiloride-sensitive cation channel 5, intestinal BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type III, beta BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide BW-723C86 Sodium Channel, Site 2 80% 2.1739uM 1.9833uM View
calcium channel, voltage-dependent, gamma subunit 4 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 3 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 2 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 1 CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
sodium channel, voltage-gated, type IX, alpha PUROMYCIN Sodium Channel, Site 2 12% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, beta 3 subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, beta 2 subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, alpha 1F subunit CINNARIZINE Calcium Channel Type L, Phenylalkylamine 83% .624uM .607uM View
calcium channel, voltage-dependent, gamma subunit 8 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, gamma subunit 7 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, gamma subunit 6 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, gamma subunit 5 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, gamma subunit 4 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, gamma subunit 3 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, gamma subunit 2 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, gamma subunit 1 FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, beta 4 subunit FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, beta 3 subunit FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, beta 2 subunit FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit FLUNARIZINE Calcium Channel Type L, Benzothiazepine 83% 1.12uM .995uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 VINORELBINE CYP450-3A4 Inhibition 82.5% 1uM NoneNone View